Skip to content

Heart Transplant Patients, Health Status and Physical Activity

Comparative Analysis of the Health Status of Heart Transplant Patients With Different Levels of Physical Activity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05282342
Enrollment
72
Registered
2022-03-16
Start date
2022-01-10
Completion date
2022-06-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease, Chronic

Brief summary

The aim of this cross-sectional observational study is (1) to assess the health status of a group of heart transplant patients and their level of physical activity, (2) and to compare the health status of a group of heart transplant patients with different levels of physical activity, with a group of healthy people classified as sedentary (due to their level of physical activity).

Interventions

DIAGNOSTIC_TESTDiagnostic tests

No intervention will be carried out. Participants of the whole groups will be underwent the same tests.

Sponsors

Luis Santos
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Heart transplant adults (18 years old) whose transplant had taken place at least twelve months before the study data was taken. * Heart transplant patients with low, moderate and high levels of physical activity, according to the results of the International Physical Activity Questionnaire - Long Form (IPAQ-L). * Healthy people with low levels of physical activity, according to the results of the International Physical Activity Questionnaire - Long Form (IPAQ-L).

Exclusion criteria

* Do not meet the eligibility criteria. * Have physical disabilities and/or other limiting pathologies that would condition their level of physical activity. * Have participated in cardiac rehabilitation programs during the twelve months prior to the study.

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular function assessment.Through study completion, an average of 1 year.Analysis of several cardiovascular variables.
Neuromuscular function assessment.through study completion, an average of 1 yearAnalysis of several neuromuscular variables.

Secondary

MeasureTime frameDescription
BalanceThrough study completion, an average of 1 year.Analysis of several balance variables.
Basic blood analysisThrough study completion, an average of 1 year.Analysis of several blood parameters
Quality of Life StatusThrough study completion, an average of 1 year.Analysis of several quality of life variables.
Functional CapacityThrough study completion, an average of 1 year.Analysis of several functional mobility variables.
FlexibilityThrough study completion, an average of 1 year.Analysis of several flexibility variables.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026